Sutter Health Plus
Mektovi (binimetinib)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: Multiple Sclerosis (MS):
    Documented Diagnosis: Yes
    Duration: 2 Month(s)
    Reauthorization Required: Yes

    Secondary Progressive Multiple Sclerosis:
    Documented Diagnosis: Yes
    Reauthorization Required: Yes

  • Prior Authorization: PA Required
  • Quantity Limit: limit maximum 30 EA PER 30 day(s)
  • Quantity Limit: 0.05 units per 1 day(s).